MS Synchronous vs Asynchronous Exercise Study
NCT07233902 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2026-01-21
Summary
This randomized controlled study aims to compare the effects of synchronous and asynchronous exercise programs on individuals diagnosed with relapsing-remitting multiple sclerosis (RRMS). Participants meeting the inclusion criteria (EDSS score between 2 and 5.5, aged 18-55) were randomly assigned to either the Synchronous Exercise Group (SEG) or the Asynchronous Exercise Group (ASEG).
The synchronous program was delivered via live online sessions using Google Meet and WhatsApp video calls, while the asynchronous program consisted of pre-recorded exercise videos accessible to participants. Both programs included structured exercises focusing on functional capacity, muscle strength, fatigue, independence, and quality of life.
The sample size was determined using G\*Power software based on previous studies in individuals with multiple sclerosis, targeting a total of 16. Statistical analyses will be conducted using SPSS 26.0. Parametric and non-parametric tests will be used depending on data distribution, with significance set at p \< 0.05.
The study seeks to improve accessibility to exercise programs for MS patients and provide evidence for the efficacy of remotely delivered synchronous versus asynchronous rehabilitation models.
Conditions
- Multiple Sclerosis
- Multiple Sclerosis (MS) - Relapsing-remitting
Interventions
- OTHER
-
Combined Exercise Program (Synchronous Delivery)
Participants receive a 12-week structured combined exercise program delivered twice weekly via live online video sessions (Google Meet or WhatsApp). Each session lasts approximately 40 minutes and included 10 minutes of warm-up, 25 minutes of strengthening and core stabilization exercises, and 5 minutes of cool-down stretching. Exercise intensity is maintained between 12 and 15 on the Borg Rating of Perceived Exertion scale. Rest periods are adjusted individually. Exercises are supervised in real time by a physiotherapist, who monitored participants' form, safety, and perceived fatigue throughout each session
- OTHER
-
Combined Exercise Program (Asynchronous Delivery)
Participants follow the same 12-week structured exercise program twice weekly using pre-recorded instructional videos. The program consists of warm-up, strengthening/core, and cool-down components identical to the synchronous arm. Participants receive detailed guidance to ensure correct posture and performance, logged each session in exercise diaries, and submitted weekly feedback to researchers. Investigators review exercise logs and provided individualized feedback via e-mail or phone. In case of difficulties, participants can contact the research team for assistance
Sponsors & Collaborators
-
The Scientific and Technological Research Council of Turkey
collaborator OTHER -
Yeditepe University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2025-10-01
- Completion
- 2025-10-29
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Exercise Booster Sessions in People With Multiple Sclerosis
NCT04913012 ·Status: COMPLETED ·Phase: NA
-
Exercise Therapy in Multiple Sclerosis
NCT04294979 ·Status: COMPLETED ·Phase: NA
-
Comparing the Acute Effects of Different Exercise Approaches in Patients With Multiple Sclerosis
NCT06721416 ·Status: COMPLETED ·Phase: NA
-
Effects of Individualized Training to Reduce Fatigue in Patients With Newly and Advanced Diagnosed Multiple Sclerosis
NCT06201026 ·Status: RECRUITING ·Phase: NA
-
Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
NCT01122056 ·Status: COMPLETED ·Phase: NA
-
The Effects of In-phase Bilateral Exercise in People with Progressive Multiple Sclerosis
NCT06436131 ·Status: COMPLETED ·Phase: NA
-
Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain Connectivity
NCT02005237 ·Status: COMPLETED ·Phase: NA
-
Exercise in Severely Disabled Patients With MS
NCT01752660 ·Status: COMPLETED ·Phase: PHASE1
-
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis
NCT04367389 ·Status: COMPLETED ·Phase: NA
-
The Impact of Exercise Training on Living Quality in Multiple Sclerosis Individuals
NCT03222596 ·Status: COMPLETED ·Phase: NA
-
Home Exercise Intervention in Persons With Multiple Sclerosis
NCT01824550 ·Status: COMPLETED ·Phase: NA
-
Exercise Intensity and Immune Function in Multiple Sclerosis
NCT02264704 ·Status: UNKNOWN ·Phase: NA
-
Exercise on Contactin-1 and Contactin-2 Level in Persons With Multiple Sclerosis
NCT05351411 ·Status: COMPLETED
-
Exercise-based Therapy for Multiple Sclerosis Patients
NCT03735524 ·Status: UNKNOWN ·Phase: NA
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
NCT06270641 ·Status: RECRUITING ·Phase: NA
-
Exercise in Multiple Sclerosis
NCT02716701 ·Status: TERMINATED ·Phase: NA
-
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis (Feasibility Study)
NCT04057066 ·Status: COMPLETED ·Phase: NA
-
Multiple Sclerosis and Progressive Resistance Training
NCT01518660 ·Status: COMPLETED ·Phase: NA
-
Effects of Resistance Training in Multiple Sclerosis: a Randomized Trial.
NCT06478784 ·Status: RECRUITING ·Phase: NA
-
The MS-LINK™ Outcomes Study
NCT04735406 ·Status: COMPLETED
-
Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation
NCT04674280 ·Status: UNKNOWN
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Comparison of Two Physical Activity Interventions in Individuals With Multiple Sclerosis
NCT02496416 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
NCT02228213 ·Status: COMPLETED ·Phase: PHASE2